|
🦁
|
Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients
10 auth.
M. Rotger,
S. Colombo,
H. Furrer,
Gabriela Bleiber,
T. Buclin,
Belle L. Lee,
...
O. Keiser,
J. Biollaz,
L. Decosterd,
A. Telenti
|
8 |
2005 |
8
🦁
|
|
🦁
|
Predictive Value of Known and Novel Alleles of CYP2B6 for Efavirenz Plasma Concentrations in HIV‐infected Individuals
13 auth.
M. Rotger,
H. Tegude,
S. Colombo,
M. Cavassini,
H. Furrer,
L. Decosterd,
J. Blievernicht,
T. Saussele,
H. Günthard,
M. Schwab,
...
M. Eichelbaum,
A. Telenti,
U. Zanger
|
8 |
2007 |
8
🦁
|
|
🐜
|
SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.
28 auth.
R. Clifford,
T. Louis,
P. Robbe,
S. Ackroyd,
A. Burns,
A. Timbs,
Glen Wright Colopy,
H. Dreau,
F. Sigaux,
J. Judde,
M. Rotger,
A. Telenti,
Yea-Lih Lin,
P. Pasero,
J. Maelfait,
...
Michalis K. Titsias,
Dena R. Cohen,
S. Henderson,
M. Ross,
D. Bentley,
P. Hillmen,
A. Pettitt,
J. Rehwinkel,
S. Knight,
Jenny C. Taylor,
Y. Crow,
M. Benkirane,
A. Schuh
|
7 |
2014 |
7
🐜
|
|
🦁
|
Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque.
27 auth.
M. Rotger,
J. Dalmau,
A. Rauch,
P. McLaren,
S. Bosinger,
Raquel Martínez,
Netanya G. Sandler,
A. Roque,
Julia C Liebner,
M. Battegay,
E. Bernasconi,
P. Descombes,
I. Erkizia,
J. Fellay,
B. Hirschel,
...
J. Miro,
E. Palou,
M. Hoffmann,
M. Massanella,
J. Blanco,
M. Woods,
H. Günthard,
P. D. de Bakker,
D. Douek,
G. Silvestri,
J. Martinez-Picado,
A. Telenti
|
7 |
2011 |
7
🦁
|
|
🦁
|
Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia.
10 auth.
M. Rotger,
P. Taffé,
Gabriela Bleiber,
H. Gunthard,
H. Furrer,
P. Vernazza,
...
H. Drechsler,
E. Bernasconi,
M. Rickenbach,
A. Telenti
|
7 |
2005 |
7
🦁
|
|
🦁
|
Genome-Wide mRNA Expression Correlates of Viral Control in CD4+ T-Cells from HIV-1-Infected Individuals
11 auth.
M. Rotger,
Kristen K. Dang,
J. Fellay,
E. Heinzen,
Sheng Feng,
P. Descombes,
...
K. Shianna,
D. Ge,
H. Günthard,
D. Goldstein,
A. Telenti
|
7 |
2010 |
7
🦁
|
|
🐜
|
In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function
13 auth.
J. Iulio,
A. Fayet,
M. Arab-Alameddine,
M. Rotger,
R. Lubomirov,
M. Cavassini,
H. Furrer,
H. Günthard,
S. Colombo,
C. Csajka,
...
C. Eap,
L. Decosterd,
A. Telenti
|
7 |
2009 |
7
🐜
|
|
🐜
|
Pharmacogenetics‐Based Population Pharmacokinetic Analysis of Efavirenz in HIV‐1‐Infected Individuals
14 auth.
M. Arab-Alameddine,
M. Arab-Alameddine,
J. D. Iulio,
T. Buclin,
M. Rotger,
R. Lubomirov,
Matthias Cavassini,
A. Fayet,
L. Decosterd,
Chin B. Eap,
...
Jérôme Biollaz,
Amalio Telenti,
C. Csajka,
C. Csajka
|
7 |
2009 |
7
🐜
|
|
🐜
|
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.
15 auth.
P. Tarr,
P. Taffé,
Gabriela Bleiber,
H. Furrer,
M. Rotger,
Raquel Martínez,
B. Hirschel,
M. Battegay,
R. Weber,
P. Vernazza,
...
E. Bernasconi,
R. Darioli,
M. Rickenbach,
B. Ledergerber,
A. Telenti
|
6 |
2005 |
6
🐜
|
|
🐜
|
The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir.
11 auth.
S. Colombo,
A. Rauch,
M. Rotger,
J. Fellay,
Raquel Martínez,
C. Fux,
...
C. Thurnheer,
H. Günthard,
D. Goldstein,
H. Furrer,
A. Telenti
|
6 |
2008 |
6
🐜
|
|
🐜
|
Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo
10 auth.
S. Colombo,
N. Soranzo,
M. Rotger,
Raimund Sprenger,
Gabriela Bleiber,
H. Furrer,
...
T. Buclin,
David Goldstein,
L. Decosterd,
A. Telenti
|
6 |
2005 |
6
🐜
|
